PARSIPPANY, N.J., Jan. 12, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that it will host an Investor Meeting on January 24, 2012 in New York City. The meeting will begin at 8:00 a.m. Eastern Time and will be simultaneously webcast.

At the meeting, the Company plans to provide a preliminary update on 2011 achievements as well as a business outlook for 2012 and beyond. Paul Bisaro, Watson's President and CEO and Todd Joyce, Executive Vice President and CFO will present the 2011 update and business outlook and will be joined for a question & answer session by Siggi Olafsson, Executive Vice President, Global Generics; Fred Wilkinson, Executive Vice President, Global Brands; Bob Stewart, Executive Vice President, Global Operations; David Buchen, Executive Vice President, General Counsel and Secretary, and Al Paonessa III, Executive Vice President and CEO, Anda, Inc.

In-person attendance at the meeting is by invitation only. The webcast will be available live to investors and the media on Watson's Web site or at the following link: http://www.videonewswire.com/event.asp?id=84459

A replay of the webcast will be available approximately two hours following the completion of the event on the Company's website.

About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.


    CONTACTS:                           Investors:
                                        Patty Eisenhaur
                                        (862) 261-8141


                                        Media:
                                        Charlie Mayr
                                        (862) 261-8030

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )

SOURCE Watson Pharmaceuticals, Inc.